Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation by Kemble, David J. & Sun, Gongqin
University of Rhode Island
DigitalCommons@URI
Cell and Molecular Biology Faculty Publications Cell and Molecular Biology
2009
Direct and specific inactivation of protein tyrosine
kinases in the Src and FGFR families by reversible
cysteine oxidation
David J. Kemble
University of Rhode Island
Gongqin Sun
University of Rhode Island, gsun@uri.edu
Follow this and additional works at: https://digitalcommons.uri.edu/cmb_facpubs
Terms of Use
All rights reserved under copyright.
This Article is brought to you for free and open access by the Cell and Molecular Biology at DigitalCommons@URI. It has been accepted for inclusion
in Cell and Molecular Biology Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact
digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Kemble, D. J., & Sun, G. (2009). Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible
cysteine oxidation. Proceedings of the National Academy of Sciences, 106(13), 5070-5075. doi: 10.1073/pnas.0806117106
Available at: https://doi.org/10.1073/pnas.0806117106
Direct and specific inactivation of protein tyrosine
kinases in the Src and FGFR families by reversible
cysteine oxidation
David J. Kemble and Gongqin Sun1
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881
Edited by Susan S. Taylor, University of California at San Diego, La Jolla, CA, and approved February 9, 2009 (received for review June 24, 2008)
Accumulating evidence suggests that protein tyrosine phosphory-
lation-based signaling pathways are under the regulation of reac-
tive oxygen species. Although protein tyrosine phosphatases are
directly regulated by reversible oxidation, it is not clear whether
protein tyrosine kinases (PTKs) are also directly regulated by
reduction/oxidation (redox). In this study we report a mechanism
of direct oxidative inactivation specific for the PTKs in the Src and
fibroblast growth factor receptor (FGFR) families, key enzymes in
mammalian signal transduction. Src is fully active when reduced
and retains 8–25% of the full activity toward various substrates
when oxidized. This inactivation is caused by oxidation of a specific
cysteine residue (Cys-277), which results in homodimerization of
Src linked by a disulfide bridge. Cys-277 is located in the Gly loop
in the catalytic domain. This cysteine residue is conserved only in
8 of the >90 PTKs in the human kinome, including 3 of the 10 Src
family kinases and all 4 kinases of the FGFR family. FGFR1 is also
reversibly regulated by redox because of this cysteine residue,
whereas Csk, a PTK that lacks a cysteine residue at the correspond-
ing position, is not similarly regulated. These results demonstrate
a mechanism of direct redox regulation conserved in certain
specific PTKs.
Reactive oxygen species (ROS), such as hydrogen peroxideand superoxide, can alter the function of proteins by oxi-
dizing free sulfhydryl groups to sulfenic, sulfinic, or sulfonic
acids (1, 2). Cellular responses to ROS are historically consid-
ered a damage-control mechanism to certain pathological situ-
ations that lead to oxidative stress. However, recent studies
indicate that certain growth factors and cell adhesion also
stimulate the production of ROS, which serve as secondary
messengers to regulate downstream signaling pathways (3, 4).
Numerous protein phosphorylation pathways respond to ROS
(5–9), and identifying the proteins and the residues sensitive to
oxidation will help elucidate the mechanism of cross-talk be-
tween redox and protein tyrosine phosphorylation.
The level of protein tyrosine phosphorylation is the function
of opposing actions of protein tyrosine kinases (PTKs) and
protein tyrosine phosphatases (PTPs). All PTPs contain a
catalytic Cys residue in the active site, and oxidation of this
residue leads to the inactivation of the PTP activity (10). This
response is recognized as a major mechanism by which ROS
regulate the level of protein tyrosine phosphorylation. However,
whether PTKs also directly respond to ROS is not established.
PTK Src is a key regulator of cell survival, cytoskeleton reor-
ganization, DNA synthesis, and cell division (11, 12). A number
of studies suggest that Src also plays an important role in cellular
response to ROS, because Src specific inhibitors and dominant-
negative Src mutants strongly attenuate cellular response to
ROS (13–16). However, how ROS regulate Src activity has been
controversial, likely reflecting the complexity of Src regulation.
Src contains regulatory structures such as a myristoylation motif,
a unique region, a Src homology 3 (SH3) domain, an SH2
domain, and a regulatory tail in addition to the catalytic domain
(11). Src activity is regulated directly by reversible phosphory-
lation on multiple Tyr and Ser residues (11, 17, 18), interaction
with cell surface receptors through its SH2 domain (19), Pro-rich
proteins through its SH3 domain (20), and activated -subunit of
trimeric G proteins (21). Thus, in cell-based studies it is often
difficult to differentiate the direct effect of redox regulation on
Src activity from the indirect effects through Src regulators. For
example, both activation (22) and inactivation (23, 24) of Src in
response to oxidative stress have been reported. This inconsis-
tency is likely because the activation or inactivation is accom-
panied by an increase in Src phosphorylation level on Tyr-416 or
Tyr-527. Because phosphorylation of Tyr-416 and Tyr-527,
respectively, activates (17) and inactivates (18) Src family ki-
nases, it is not clear whether ROS directly regulate Src kinases
or simply inactivate the PTPs that dephosphorylate these Tyr
phosphorylation sites.
In the current study, we use purified Src enzyme and mutants
to demonstrate a direct and specific Src response to ROS and
identify the underlying mechanistic basis for the response. Src is
fully active when reduced and inactivated by oxidation. When
oxidized, Src forms a disulfide-linked dimer between 2 Cys-277
residues. Further, fibroblast growth factor receptor type 1
(FGFR1), as one of the few PTKs with a corresponding Cys
residue, is also inactivated by oxidation because of this Cys
residue, whereas Csk, which lacks a corresponding Cys residue,
is not similarly regulated. These results reveal a distinct mech-
anism for redox regulation of specific PTKs.
Results
Sensitivity of Src Kinase Activity to Reducing/Oxidizing Conditions.
Given the inconsistency in the literature regarding Src response
to ROS, we sought to address this issue directly by using purified
Src enzyme. To determine whether Src kinase activity directly
responds to redox modulation, the kinase activity of purified Src
was determined in the presence of varying concentrations of
DTT. The Src protein is purified by Ni2-affinity chromatogra-
phy in the absence of a reducing agent. As shown in Fig. 1A, Src
has a turnover number of 30 min1 in the absence of DTT, and
the activity increases to 400 min1 in the presence of 1 mM or
higher concentrations of DTT. This activation of 13-fold is not
caused by DTT-chelating metal cation inhibitors that might be
present in the assay medium, because the addition of 0.2 mM
ethylene diamine tetraacetic acid only slightly stimulates the
kinase activity (Fig. 1B). This strong activation by the reducing
condition is not observed for another PTK, Csk, which is only
mildly activated by DTT (Fig. 1A). The modest activation of Csk
by DTT is caused by the reduction of a disulfide bond between
Cys-122 and Cys-164 located in the SH2 domain (25). We also
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tested whether Src activity responds to the presence of H2O2.
The presence of up to 20 mM H2O2 has no effect on Src kinase
activity directly, but it can reverse the activation by DTT over
time. These observations indicate that the absence of a reducing
agent alone is sufficiently oxidizing to cause Src inactivation.
These results indicate that Src kinase activity is specifically
sensitive to redox modulation and suggest that there is a specific
redox-sensing mechanism built into the structure of Src.
Cys-277 Is Responsible for Src Oxidation. The sensitivity of Src
activity to oxidation suggests that certain Cys residues in Src are
prone to reversible oxidation that inactivates Src. The Src
enzyme contains 9 Cys residues. To determine which Cys residue
is responsible for oxidation, each Cys residue was individually
mutated to Ala and the mutant enzymes were purified (Fig. 2A).
The kinase activities of these mutant enzymes in the presence
and absence of 1 mMDTT were determined (Fig. 2B). Although
the mutations have varying effects on the kinase activity, all
except 1 mutant retain a clear activation by DTT. The lone
exception is Src-Cys-277–Ala (Src-C277A), which displays ap-
proximately the same kinase activity in the presence and absence
of DTT (Fig. 2B), indicating that Cys-277 alone is responsible for
the redox sensitivity. Indeed, Src-C277A completely loses its
dose-dependent activation by DTT (Fig. 2C) and remains fully
active even in the absence of any reducing agent, whereas all
other mutants display a dose-dependent activation by DTT (Fig.
2C). It is noted that some mutants are less sensitive to activation
by DTT compared with WT Src, but they still respond to
activation by DTT, indicating that the redox-sensitive Cys resi-
due is still present in these mutants.
The above analysis used polyE4Y, a copolymer of Glu and Tyr
in the ratio of 4:1, as a substrate. To confirm the redox effect on
Src kinase activity with physiological Src substrates, we deter-
mined the effect of 2 mM DTT of Src phosphorylation of 2
physiological substrates Src (kinase-defective Src) and cortactin
(Fig. 2D). DTT (2 mM) stimulates Src activity 4-fold toward
either substrate according to scintillation counting of the gel
slices. Mutation of C277A abolished the sensitivity to DTT.
These results indicate that oxidative inactivation of Src also
applies to physiological substrates.
WT Src Forms a Cys-277-Dependent Disulfide Dimer When Oxidized.A
Cys residue can be oxidized to 3 different states, sulfenic
(SOH), sulfinic (SO2H), or sulfonic (SO3H) acid. Two
Cys-sulfenic groups can form a disulfide bond, which can be
reversed by reduction. Alternatively, a Cys-sulfenic group can
also form a sulfenyl-amide intermediate with a neighboring
backbone amine, which is also reversible (26, 27). Both mech-
anisms would prevent the Cys-sulfenic group from further
oxidation to a sulfonic group, which cannot be reduced back to
the free sulfhydryl group (1). In the tertiary structure of Src (28),
Cys-277 is not near any other Cys residue. For it to form an
intramolecular disulfide bond with any other Cys residue would
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Fig. 1. Responses of Src and Csk kinase activity to DTT. (A) The kinase
activities of Src and Csk at different concentrations of DTT were determined
as described. The results are based on 3 independent assays, with standard
errors represented by the error bars. (B) Effects of 1 mM DTT and 1 mM EDTA
individually or in combination on Src kinase activity.
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Fig. 2. Src Cys-to-Ala mutants and their responses to DTT. (A) WT Src and 9
Cys-Ala mutants were analyzed by SDS/PAGE under reducing conditions. Two
micrograms of protein was loaded in each lane, and the gel was stained by
Coomassie brilliant blue. (B) The kinase activity ofWT Src and Cys-Alamutants
in the presence of absence of 1 mM DTT. (C) Dose-dependent activation of
selected Cys-Ala mutants of Src. The activity of each enzyme in the absence
of the reducing agent is used as the base, and the fold of activation is the fold
of increase at a given DTT concentration over that base level. (D) Phosphor-
ylation of kdSrc and cortactin by Src (wt) and Src-C277A (CA) in the presence
or absence of 2 mM DTT. The Src and DTT combinations are indicated on the
top, and the substrates are indicated at the bottom. (Upper) Coomassie
blue-stained gels. (Lower) Autoradiograms.
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require gross alterations to the tertiary structure. We tested
whether Src forms a dimer linked by an intermolecular disulfide
bond. When WT Src is fractionated in the presence of -
mercaptoethanol, it runs as a 55-kDa protein, the expected size
of the monomeric Src (Fig. 3A Left). In the absence of the
reducing agent, while a majority of Src runs as the monomer, a
significant portion runs as a 110-kDa protein, the apparent
molecular mass of a dimer. Incubation of Src with H2O2 results
in a significant increase in the 110-kDa band and a simultaneous
decrease in the monomer. These observations indicate that when
Src is purified in the absence of a reducing agent a significant
portion is present as a dimer, and the dimer can be reduced into
monomers by a reducing agent.
If oxidized Src indeed forms a disulfide dimer, and Cys-277 is the
residue that is oxidized, then Src-C277Amutant would be expected
not to form such a disulfide dimer. Indeed, no dimer is detectable
under any of the conditions that lead to significant dimer formation
for WT Src (Fig. 3A Right). This result demonstrates that dimer
formation by oxidized Src depends on Cys-277.
Although the above results compellingly demonstrate that the
disulfide dimerization of Src depends on Cys-277, they do not
exclude the possibility that the disulfide bond is between Cys-277
of one Src molecule and a different Cys residue in another
Src molecule. To test this possibility, we examined whether
radioactively-labeled Src-C277A could form a disulfide dimer with
unphosphorylatedWTSrc. If the disulfide bond is betweenCys-277
of one molecule to a different Cys residue in another molecule,
Src-C277A would be able to form a disulfide dimer with WT Src.
Radioactively-labeled WT Src or Src-C277A was mixed with equal
amounts of unlabeled WT Src, and the mixtures were fractionated
by SDS/PAGE (Fig. 3B). Under reducing condition, WT Src or
C277A does not dimerize either alone or in the presence of
unlabeled WT Src. Under oxidizing condition, labeled WT Src
dimerizes either alone or when mixed with unlabeled WT Src.
However, oxidizing condition does not lead to dimer formation
between Src-C277A andWTSrc (Fig. 3B). This result indicates that
no other Cys residue in Src-C277A is capable of forming disulfide
bond with a Cys-277 from the WT Src. Thus, the intermolecular
disulfide bond is formed between 2 Cys-277 residues in 2 Src
molecules when oxidized. This result is consistent with the fact that
no other Cys residue is found to be required for the redox sensitivity
by the mutagenic analysis presented earlier.
FGFR1 Responds to Redox Regulation in a Similar Manner. The
identification of Cys-277 of Src as the redox sensor raises the
question of whether this regulation is unique to Src or is also
present in other PTKs. Cys-277 in Src is located in the small
N-terminal lobe of the catalytic domain in the sequence context
of GQGCFG, referred to as the Gly loop. The 3 Gly residues are
a universally-conserved signature motif among all protein ki-
nases, even though the intervening residues are variable. Kinetic
and structural studies of both protein Ser/Thr kinase, cAMP-
dependent protein kinases (29), and a PTK, FPS (30), indicate
that this loop is directly involved in catalysis. An examination of
the amino acid sequences of all human PTKs indicates that only
a small number of PTKs contain a Cys residue at the position
equivalent to Cys-277 in Src (Table S1). Among the 10 members
of the Src kinase family, only 3 (Src, Yes, and Fgr) contain a Cys
residue, whereas most other members contain a Gln at the
corresponding position. The receptor kinases in the FGFR
family contain 4 members, FGFR1 through FGFR4, and all
contain a Cys residue (Cys-488 in FGFR1) at the equivalent
position. Only 1 additional PTK, Tnk1 in the Ack family, in the
human tyrosine kinome contains a Cys at the equivalent posi-
tion, which raises the possibility that the identified mechanism of
redox regulation is conserved in and unique to these PTKs. As
a representative of the FGFR family, FGFR1 was next tested for
its sensitivity to redox modulation.
Both FGFR1-WT and FGFR1–Cys-488–Ala were expressed
and purified (Fig. 4A). The kinase activity of FGFR1-WT has a
strong dependence on the presence of DTT. It has a kinase
activity of 8 min1 in the absence of a reducing agent and is
activated to an activity of 51 min1 by DTT in a dose-dependent
manner. The mutation of Cys-488–Ala completely abolishes the
sensitivity of FGFR1 activity to DTT and renders FGFR1 fully
active regardless of the redox condition (Fig. 4C). This result
demonstrates that FGFR1 is also subject to redox regulation
because of the Cys residue in the Gly loop. FGFR1 also forms
a disulfide-linked dimer under oxidizing condition. However,
mutation of Cys-488–Ala did not completely abolish the dimer-
ization, indicating that oxidation of other Cys residues may also
result in dimerization.
We then determined whether a Cys residue at the equivalent
position is sufficient to confer redox sensitivity to a kinase that
is otherwise insensitive to redox. As shown earlier, Csk is
marginally sensitive to redox modulation because of the forma-
tion of an intramolecular disulfide bond in the SH2 domain (25).
Csk contains a Glu residue, Glu-205, at the position equivalent
to Cys-277 of Src. A Cskmutant (Csk–Glu-205–Cys) was purified
and tested for its response to redox (Fig. 4 B and D). Although
WT Csk is activated by DTT only marginally, Csk–Glu-205–Cys
is activated20-fold by 2 mMDTT, from 2.8 min1 to 59 min1
(Fig. 4D). This result demonstrates that Csk and potentially
other PTKs could be made redox-sensitive by the introduction of
a Cys residue at this position.
Residue Identity at the Cys-277 Position in Src and the Equivalent
Position in Csk Dictate the Kinase Activity. The fact that oxidation
of the Cys residue in the Gly loop can inactivate a PTK suggests
that the Gly loop is a motif sensitive to regulation. Thus, the
identity of the residue at this position would be expected to
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dictate the kinase activity. To test this idea, Cys-277 in Src and
Glu-205 in Csk were mutated to several representative residues,
Ala, Gln, Arg, and Ser, in addition to Cys and Glu. In both Csk
and Src, the most active residue is Ala, and the least active is Arg,
rendering10% of that of Ala (Fig. 5). A reduced Cys gives both
kinases 65% of the activity of the Ala mutants. There is
significant variation regarding Gln, Ser, and especially Glu.
Although the activity of Csk with a Glu at this position is close
to that of Ala, Src with a Glu at this position displays only 20%
of the activity of the Ala mutant, which provides an explanation
for the selection of Glu by Csk. Overall, these results support the
idea that the identity of the residue at this position dictates the
catalytic activity of a kinase.
Discussion
Several studies have demonstrated an important role of Src in
cell response to ROS (13–16), but how Src responds to ROS has
not been determined. This current study, using purified Src
enzyme and mutants, elucidates a mechanism by which Src is
directly inactivated by oxidation. The inactivation is caused by
oxidation of Cys-277, which leads to the formation of a disulfide
homodimer. Furthermore, this mechanism is uniquely con-
served in part of the Src family and the FGFR family. These
findings provide a distinct mechanism for ROS to directly
regulate signaling by Src and FGFR kinases. Our study defines
a mechanism by which a group of specific kinases are directly
regulated by ROS. A recent study demonstrates that Src is
directly oxidized in cells under oxidative stress (22), but the Cys
residue responsible for oxidation has not been identified.
The approach in this current study has one clear advantage
over cell-based studies in defining the effect of oxidation on Src
activity and the underlying mechanism for the effect. The effects
of oxidation on Src have been inconsistent in the literature. Some
reports suggest that Src is activated by ROS (22), whereas others
indicate that Src is inactivated (23, 24). A survey of the literature
identifies 2 potential reasons for this inconsistency. First, Src is
regulated by numerous mechanisms, such as activation by auto-
phosphorylation on Tyr-416, ligands to the SH3 and SH2
domains, and activated G proteins, and inactivation by phos-
phorylation on Tyr-527. It is difficult to distinguish whether the
effect of ROS is caused by direct oxidation of Src or indirectly
through other regulatory mechanisms. Indeed, reported Src
activation by ROS is accompanied by increased phosphorylation
on Tyr-416 (22), whereas inactivation is invariably accompanied
by increased phosphorylation of Tyr-527 (23, 24). Second,
cell-based studies rely on immunoprecipitation to isolate Src.
The redox state of a given Cys residue can be readily altered
during cell lysis and immunoprecipitation, thus the final redox
state of immunoprecipitated Srcmay not correlate to the original
treatment to the cells. This reversibility precludes any reliable
conclusion about a relationship between the final Src activity
level and the original treatment. In contrast, using purified
enzymes and mutants, the direct effects of oxidation can be
determined without the interference by other regulatory mech-
anisms, and the Cys residue responsible for the oxidation can be
identified.
How the oxidative inactivation of Src fits in the overall regulation
of Src kinases remains to be determined. Because Src is under the
regulation of numerous mechanisms, redox regulation could cross-
talk with any of these mechanisms in addition to directly affecting
Src kinase activity. The cross-talk could occur on 2 levels. First,
ROS may regulate any of the upstream regulatory kinases, phos-
phatases and G proteins, which would indirectly regulate Src
activity. For example, the SH2 domain of Csk contains a novel
disulfide bond, whichmodulates the Csk activity (25). By regulating
Csk activity, ROS could indirectly alter Src activity. Second, oxi-
dation of Cys-277 of Src may alter how Src responds to any of these
other regulatory mechanisms. For example, a recent structural
study (31) reveals a disulfide bond between Src Cys-277 and Csk
Cys-290, linking Src from oneCsk–Src kinase–substrate complex to
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Fig. 4. Sensitivity of FGFR1 and Csk to redox regulation. (A) WT FGFR1
catalytic domain and a Cys-488–Ala mutant were purified. (B) WT Csk and a
Glu-205–Ala mutant were purified. (C) The kinase activity (turnover number)
of FGFR1 and FGFR1–Cys-488–Ala as a function of DTT concentration in the
kinase assay. (D) The kinase activity (turnover number) of Csk and Csk–Glu-
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Csk from another Csk–Src complex. We demonstrate (Fig. S1) that
oxidized Src actually prefers Csk as a partner for forming disulfide
dimer. It is possible that redox regulation could modulate Src
phosphorylation and/or the subsequent inactivation by Csk. It is
worth noting that only Src, Yes, and Fgr contain a Cys residue in
the Gly loop. This selectivity could provide a mechanism for
specifically regulating some Src kinases. The physiological implica-
tions of these observations remain to be examined.
The finding of Cys-277 being responsible for Src oxidation
raises the questions of why a Cys residue is sensitive to oxidation
whereas others are not. Cys-277 is located in the Gly loop of the
Src catalytic domain. In the crystal structure of Src (28), the side
chain of Cys-277 is readily accessible, which may explain its
sensitivity to oxidation. Furthermore, kinase activity appears
particularly sensitive to modification to the Gly (29, 30), as
demonstrated for Src and Csk. All of these observations provide
a mechanistic basis for the redox regulation at this residue.
Disulfide dimer formation has not been previously reported for
Src or FGFR. However, a symmetric dimer of FGFR2 has been
recently reported (ref. 32; Protein Data Bank ID code 2PSQ).
Even though a disulfide bond is not assigned in this structure, the
2 sulfur atoms from the equivalent Cys residues are only 3 Å
apart, leaving the distinct possibility that a disulfide bridge can
be formed between the 2 molecules of FGFR2.
The fact that only a small number of PTKs have the correspond-
ing Cys residue suggests specificity to this potential regulation. Of
94 human PTKs, only 8 contain a Cys residue in the Gly loop: 4
members of the FGFR family, 3 in the Src family, and TNK1 of the
Ack family. A thorough literature search identified no report of
redox regulation of FGFRs, TNK1, Yes, or Fgr. Further investi-
gation is required to determine how redox regulation fits into
signaling by these kinases. The fact that the redox regulation is
limited to select PTKs contrasts the situation in PTPs, all of which
are inactivated by oxidation (10). This, of course, does not exclude
other potential mechanisms by which a PTK may respond to redox
regulation. Janus kinase 2 is also reversibly inactivated by oxidation
(9) although it does not contain a Cys residue in the Gly loop.
Materials and Methods
Reagents and Chemicals. All reagents used for bacterial culture and protein
expression were purchased from Fisher. The chromatographic resin, iminodi-
acetic acid-Agarose, was purchased from Sigma. DNA primers were synthe-
sized by Integrated DNA Technologies. [-32P]ATP (6,000 Cimol1) was pur-
chased from PerkinElmer.
PlasmidConstruction.TheplasmidpRSET-Srcwas constructedasdescribed (33).
Src mutants were generated by introducing specific residue substitutions by
using QuikChange (Stratagene). The pRSET-Src and mutant plasmids were
introduced into Escherichia coli BL21 (DE3) cells harboring the pREP4groESL
plasmid and pCDF-PTP1B by electroporation. The plasmid pREP4groESL con-
tains the genes for theGroES/EL chaperone,which helps the correct folding of
Src (34). The pCDF-PTP1B directs the expression of PTP1B, which keeps Src
dephosphorylated and reduces the toxicity of Src expression to bacterial cells
(35). The catalytic domain of FGFR1, Csk, and their respective mutants were
expressed by the same system.
Protein Expression and Purification. Src, Csk, FGFR1, and their mutants were
expressed and purified as described below. In a 2-L flask, a single bacterial
colony containing recombinant plasmids was inoculated into 400 mL of LB
culture medium containing appropriate antibiotics. The cultures were grown
to an OD600 of 2.5 and diluted with 400 mL of fresh LB containing the
antibiotics. The cultures were air-cooled to 25 °C, and 0.4 mM isopropyl--
D-thiogalactopyranoside was added to induce the production of the fusion
protein. Cultureswere allowed to induce for 4 h at 25 °Cduring shaking at 250
rpm g. Bacterial cultures were harvested by centrifugation at 4,500 g and
stored at 20 °C.
Bacterial cell pellets were resuspended with ice-cold lysis buffer [50 mM
Hepes (pH 8.0), 200mMNaCl, 5 mM imidazole, and 0.1% Triton-X]. Cells were
lysed by sonication and clarified by centrifugation at 47,800 g for 30 min at
4 °C. The supernatant was added to 1.2 mL of iminodiacetic acid-Agarose
beads chargedwith NiCl2 and gently mixed by rotation at 4 °C for 30min. The
beadswere loaded into a columnand thenwashedwithwashbuffer 1 (50mM
Hepes, pH8.0, and10mMimidazole),washbuffer 2 (50mMHepes, pH8.0, and
20 mM imidazole), and wash buffer 3 (50 mM Hepes, pH 8.0, and 30 mM
imidazole). Proteins were eluted by using 200–500 mM imidazole in 50 mM
Hepes (pH 8.0). Enzymes were desalted and stored in 50mMHepes (pH 8.0) at
20 °C in 40% glycerol. Protein concentration was determined by Bradford
Reagent (BioRad) standardized with BSA (0.2–1.0 mgmL1). Purity of protein
fractions was determined by 12% SDS/PAGE (BioRad) and stained with Coo-
massie blue.
Kinase Assays. For quantifying PTK activities, we measured the phosphoryla-
tion of polyE4Y by using the acid precipitation assay (36). Standard assay
reactions of 50L contained 75mM4-(2-Hydroxyethyl)-1-piperazinepropane-
sulfonic acid (EPPS) (pH 8.0), 1 mgmL1 polyE4Y, 200 M [32]ATP (1,000
dpm/pmol), 12 mM MgCl2, 5% glycerol, and 0.005% Triton X-100. To deter-
mine the effect of reducing or oxidizing agents, DTT or H2O2, at the indicated
concentrations were included in the reaction mixture. All assays were per-
formed at least 3 times, and the reported activities are the average with
standard errors.
To determine the effect of DTT on Src activity toward kdSrc or cortactin, 1
nM Src or Src-C277A was incubated with 10 M kdSrc or cortactin in the
presence or absence of 2 mMDTT under otherwise standard phosphorylation
conditions for 30min. (His)6-tagged cortactinwas expressedandpurified from
bacteria. The reaction was terminated by the addition of SDS/PAGE sample
buffer containing 2% -mercaptoethanol. Samples were boiled for 5min and
fractionated by 12% SDS/PAGE, and the gels were stained with Coomassie
blue. The level of phosphorylation was determined by autoradiography and
scintillation counting of the excised bands.
Analysis of Dimer Formation. Disulfide dimers were visualized by SDS/PAGE in
the absence of 2% -mercaptoethanol and Coomassie blue staining, or auto-
radiography when the proteins were radioactively labeled. WT Src and Src-
C277A were labeled with 32P by incubating 1 mg of each protein with 2 mM
DTT, 200M[32]ATP (2,500 cpm/pmol), and 12mMMgCl2 in the kinase assay
buffer for 60 min at 30 °C. The labeled proteins were desalted on Econo-Pac
10DG columns (BioRad) equilibrated with 50 mM Hepes, 1 mM EDTA, and 1
mM DTT (pH 8.0). Approximately 10 g of each protein, labeled and/or
nonlabeled, was combined in the presence of 1mMDTT tomaintain Src in the
monomer form. Samples were then subjected to oxidizing conditions by
the additionof 20mMH2O2, boiled for 5min in SDS/PAGE sample buffer in the
presence or absence of 2% -mercaptoethanol, and fractionated by 10%
SDS/PAGE stained with Coomassie blue. Radioactively-labeled fractions were
visualized by exposing gel to autoradiographic film (Sigma) for 2 h.
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